FLAG

NYSE

First Light Acquisition Group Inc.

SectorHealth CareIndustryBiotechnology: Biological Products (No Diagnostic Substances)IPO2021

$27.42+19.98 (+268.55%)

News25/Ratings0

First Light Acquisition Group, Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is headquartered in Reston, Virginia.

Latest news

25 items

799d13D/G
SEC Form SC 13G/A filed by First Light Acquisition Group Inc. (Amendment)
SC 13G/A - Calidi Biotherapeutics, Inc. (0001855485) (Subject)
800d13D/G
SEC Form SC 13G/A filed by First Light Acquisition Group Inc. (Amendment)
SC 13G/A - Calidi Biotherapeutics, Inc. (0001855485) (Subject)
801d13D/G
SEC Form SC 13G/A filed by First Light Acquisition Group Inc. (Amendment)
SC 13G/A - Calidi Biotherapeutics, Inc. (0001855485) (Subject)
801d13D/G
SEC Form SC 13G/A filed by First Light Acquisition Group Inc. (Amendment)
SC 13G/A - Calidi Biotherapeutics, Inc. (0001855485) (Subject)
802dSEC
First Light Acquisition Group Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
8-K - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
802dSEC
SEC Form 424B3 filed by First Light Acquisition Group Inc.
424B3 - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
804d13D/G
SEC Form SC 13G/A filed by First Light Acquisition Group Inc. (Amendment)
SC 13G/A - Calidi Biotherapeutics, Inc. (0001855485) (Subject)
805d13D/G
SEC Form SC 13G/A filed by First Light Acquisition Group Inc. (Amendment)
SC 13G/A - Calidi Biotherapeutics, Inc. (0001855485) (Subject)
807dSEC
First Light Acquisition Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure
8-K - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
807dSEC
SEC Form S-1/A filed by First Light Acquisition Group Inc. (Amendment)
S-1/A - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
812dSEC
SEC Form 424B3 filed by First Light Acquisition Group Inc.
424B3 - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
812dSEC
First Light Acquisition Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
8-K - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
816dSEC
SEC Form S-1 filed by First Light Acquisition Group Inc.
S-1 - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
821dSEC
SEC Form 424B3 filed by First Light Acquisition Group Inc.
424B3 - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
823dSEC
SEC Form EFFECT filed by First Light Acquisition Group Inc.
EFFECT - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
829dSEC
SEC Form S-1/A filed by First Light Acquisition Group Inc. (Amendment)
S-1/A - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
837dSEC
First Light Acquisition Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
837dSEC
SEC Form S-1/A filed by First Light Acquisition Group Inc. (Amendment)
S-1/A - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
840dSEC
First Light Acquisition Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Calidi Biotherapeutics, Inc. (0001855485) (Filer)
840dINSIDER
Zulueta Alfonso G was granted 5,644 shares, increasing direct ownership by 4% to 133,301 units (SEC Form 4)
4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
840dINSIDER
Stewart Alan R. was granted 7,282 shares, increasing direct ownership by 15% to 54,655 units (SEC Form 4)
4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
840dINSIDER
Schoeneck James A was granted 10,625 shares, increasing direct ownership by 62% to 27,872 units (SEC Form 4)
4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
840dINSIDER
Leftwich Scott was granted 8,958 shares, increasing direct ownership by 2% to 469,903 units (SEC Form 4)
4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
840dINSIDER
SEC Form 4 filed by Camaisa Allan
4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
849dINSIDER
Vecchiolla Thomas A. was granted 7,709 shares, increasing direct ownership by 2% to 365,105 units (SEC Form 4)
4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)